CNBC • 19 hours ago
Momenta says Pfizer, a key supplier for its multiple sclerosis drug, has received a warning letter from the Food and Drug Administration.
Associated Press • 21 hours ago
Momenta Pharmaceuticals Inc. on Tuesday reported fourth-quarter net income of $41.5 million, after reporting a loss in the same period a year earlier. The Cambridge, Massachusetts-based company said it ...
Zacks • 2 days ago
Here we have three pharma companies that are set to report fourth-quarter results on Feb 21. Let's see how things are shaping up for this quarter.
Zacks • 8 days agoThe Zacks Analyst Blog Highlights: MidWestOne Financial Group, Brooks Automation, Cross Country Healthcare, Francesca's Holdings and Momenta Pharmaceuticals
The Zacks Analyst Blog Highlights: MidWestOne Financial Group, Brooks Automation, Cross Country Healthcare, Francesca's Holdings and Momenta Pharmaceuticals
MNTA : Summary for Momenta Pharmaceuticals, Inc. - Yahoo Finance
Momenta Pharmaceuticals, Inc. (MNTA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||15.00 x 200|
|Ask||16.50 x 100|
|Day's Range||14.70 - 16.64|
|52 Week Range||7.86 - 19.90|
|PE Ratio (TTM)||-10.52|
|Earnings Date||Feb 16, 2017 - Feb 20, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||17.50|